Aggregation and Chemical Modification of Monoclonal Antibodies under Upstream Processing Conditions.
- Published in:
- Pharmaceutical Research, 2013, v. 30, n. 5, p. 1380, doi. 10.1007/s11095-013-0977-8
- By:
- Publication type:
- Article
Works matching IS 07248741 AND DT 2013 AND VI 30 AND IP 5
Results: 22
1
2
Efficacy of Aerosolized Celecoxib Encapsulated Nanostructured Lipid Carrier in Non-small Cell Lung Cancer in Combination with Docetaxel.
- Published in:
- Pharmaceutical Research, 2013, v. 30, n. 5, p. 1435, doi. 10.1007/s11095-013-0984-9
- By:
- Publication type:
- Article
3
The Photolysis of Disulfide Bonds in IgG1 and IgG2 Leads to Selective Intramolecular Hydrogen Transfer Reactions of Cysteine Thiyl Radicals, Probed by Covalent H/D Exchange and RPLC-MS/MS analysis.
- Published in:
- Pharmaceutical Research, 2013, v. 30, n. 5, p. 1291, doi. 10.1007/s11095-012-0968-1
- By:
- Publication type:
- Article
4
In Vitro and In Vivo Evaluation of Lipofufol, a New Triple Stealth Liposomal Formulation of Modulated 5-Fu: Impact on Efficacy and Toxicity.
- Published in:
- Pharmaceutical Research, 2013, v. 30, n. 5, p. 1281, doi. 10.1007/s11095-012-0967-2
- By:
- Publication type:
- Article
5
Effects of Ionic Strength and Sugars on the Aggregation Propensity of Monoclonal Antibodies: Influence of Colloidal and Conformational Stabilities.
- Published in:
- Pharmaceutical Research, 2013, v. 30, n. 5, p. 1263, doi. 10.1007/s11095-012-0965-4
- By:
- Publication type:
- Article
6
Recombinant High Density Lipoprotein Nanoparticles for Target-Specific Delivery of siRNA.
- Published in:
- Pharmaceutical Research, 2013, v. 30, n. 5, p. 1203, doi. 10.1007/s11095-012-0957-4
- By:
- Publication type:
- Article
7
Preclinical Pharmacokinetic/Pharmacodynamic Models to Predict Schedule-Dependent Interaction Between Erlotinib and Gemcitabine.
- Published in:
- Pharmaceutical Research, 2013, v. 30, n. 5, p. 1400, doi. 10.1007/s11095-013-0978-7
- By:
- Publication type:
- Article
8
Rapid Vaccination Using an Acetalated Dextran Microparticulate Subunit Vaccine Confers Protection Against Triplicate Challenge by Bacillus Anthracis.
- Published in:
- Pharmaceutical Research, 2013, v. 30, n. 5, p. 1349, doi. 10.1007/s11095-013-0975-x
- By:
- Publication type:
- Article
9
Ternary Complexes with Core-Shell Bilayer for Double Level Targeted Gene Delivery: In Vitro and In Vivo Evaluation.
- Published in:
- Pharmaceutical Research, 2013, v. 30, n. 5, p. 1215, doi. 10.1007/s11095-012-0960-9
- By:
- Publication type:
- Article
10
Ternary Polymeric Nanoparticles for Oral siRNA Delivery.
- Published in:
- Pharmaceutical Research, 2013, v. 30, n. 5, p. 1228, doi. 10.1007/s11095-012-0961-8
- By:
- Publication type:
- Article
11
AAPS Connection.
- Published in:
- Pharmaceutical Research, 2013, v. 30, n. 5, p. 1464, doi. 10.1007/s11095-013-1020-9
- Publication type:
- Article
12
Understanding the Effect of Environmental History on Bilayer Tablet Interfacial Shear Strength.
- Published in:
- Pharmaceutical Research, 2013, v. 30, n. 5, p. 1300, doi. 10.1007/s11095-012-0969-0
- By:
- Publication type:
- Article
13
Fluorogenic Tagging Methodology Applied to Characterize Oxidized Tyrosine and Phenylalanine in an Immunoglobulin Monoclonal Antibody.
- Published in:
- Pharmaceutical Research, 2013, v. 30, n. 5, p. 1311, doi. 10.1007/s11095-012-0970-7
- By:
- Publication type:
- Article
14
Design and Characterization of a Novel Fluorinated Magnetic Resonance Imaging Agent for Functional Analysis of Bile Acid Transporter Activity.
- Published in:
- Pharmaceutical Research, 2013, v. 30, n. 5, p. 1240, doi. 10.1007/s11095-012-0963-6
- By:
- Publication type:
- Article
15
Importance of Peptide Transporter 2 on the Cerebrospinal Fluid Efflux Kinetics of Glycylsarcosine Characterized by Nonlinear Mixed Effects Modeling.
- Published in:
- Pharmaceutical Research, 2013, v. 30, n. 5, p. 1423, doi. 10.1007/s11095-013-0980-0
- By:
- Publication type:
- Article
16
Brain Extracellular γ-hydroxybutyrate Concentrations are Decreased by L-lactate in Rats: Role in the Treatment of Overdoses.
- Published in:
- Pharmaceutical Research, 2013, v. 30, n. 5, p. 1338, doi. 10.1007/s11095-013-0973-z
- By:
- Publication type:
- Article
17
Bioresponsive Deciduous-Charge Amphiphiles for Liposomal Delivery of DNA and siRNA.
- Published in:
- Pharmaceutical Research, 2013, v. 30, n. 5, p. 1362, doi. 10.1007/s11095-013-0976-9
- By:
- Publication type:
- Article
18
A New Approach to Dissolution Testing by UV Imaging and Finite Element Simulations.
- Published in:
- Pharmaceutical Research, 2013, v. 30, n. 5, p. 1328, doi. 10.1007/s11095-013-0972-0
- By:
- Publication type:
- Article
19
Synthetic FXR Agonist GW4064 Prevents Diet-Induced Hepatic Steatosis and Insulin Resistance.
- Published in:
- Pharmaceutical Research, 2013, v. 30, n. 5, p. 1447, doi. 10.1007/s11095-013-0986-7
- By:
- Publication type:
- Article
20
Emerging Topics in Structure-Based Virtual Screening.
- Published in:
- Pharmaceutical Research, 2013, v. 30, n. 5, p. 1458, doi. 10.1007/s11095-013-1012-9
- By:
- Publication type:
- Article
21
Engineered Andrographolide Nanoparticles Mitigate Paracetamol Hepatotoxicity in Mice.
- Published in:
- Pharmaceutical Research, 2013, v. 30, n. 5, p. 1252, doi. 10.1007/s11095-012-0964-5
- By:
- Publication type:
- Article
22
In Vivo and Ex Vivo Inhibition of Spinal Nerve Ligation-Induced Ectopic Activity by Sodium Channel Blockers Correlate to In Vitro Inhibition of NaV1.7 and Clinical Efficacy: A Pharmacokinetic-Pharmacodynamic Translational Approach.
- Published in:
- Pharmaceutical Research, 2013, v. 30, n. 5, p. 1409, doi. 10.1007/s11095-013-0979-6
- By:
- Publication type:
- Article